Introduction {#Sec1}
============

Magnetic separation is an emerging technology that uses magnetism for the efficient separation of micrometre-sized para- and ferromagnetic particles from chemical or biological suspensions. Enrichment of low-grade iron ore, removal of ferromagnetic impurities from large volumes of boiler water in both conventional and nuclear power plants, or the removal of weakly magnetic coloured impurities from kaolin clay are typical examples of magnetic separation in traditional industries. The application of these techniques in biosciences had been restricted and of limited use up to the 1970s. The idea of using magnetic separation techniques to purify biologically active compounds (nucleic acids, proteins, etc.), cells, and cell organelles led to a regrowing interest over the last decade. New magnetic particles with improved properties were developed for the partly complicated separation processes in these fields \[see reviews: Olsvik et al. [@CR35]; Safarik and Safarikova [@CR41]; Franzreb et al. [@CR20]\].

Magnetic separation of nucleic acids has several advantages compared to other techniques used for the same purpose. Nucleic acids can be isolated directly from crude sample materials such as blood, tissue homogenates, cultivation media, water, etc. The particles are used in batch processes where there are hardly any restrictions with respect to the sample volumes. Due to the possibility of adjusting the magnetic properties of the solid materials, they can be removed relatively easily and selectively even from viscous sample suspensions. In fact, magnetic separation is the only feasible method for the recovery of small particles (diameter approx. 0.05--1 μm) in the presence of biological debris and other fouling material of similar size. Furthermore, the efficiency of magnetic separation is especially suited for large-scale purifications (Safarik et al. [@CR42]; Franzreb et al. [@CR20]).

These upcoming separation techniques also serve as a basis of various automated low- to high-throughput procedures that allow to save time and money. Centrifugation steps can be avoided and the risk of cross-contamination when using traditional methods is no longer encountered. Various types of magnetic particles are commercially available for nucleic acid purification, magnetic separators working in the manual and automated mode are offered. A short description of traditional and magnetic separation methods for nucleic acid isolation, together with a short overview of batch and automated separators, will be given below.

Nucleic acid purification methods {#Sec2}
=================================

The isolation of DNA or RNA is an important step before many biochemical and diagnostic processes. Many downstream applications such as detection, cloning, sequencing, amplification, hybridisation, cDNA synthesis, etc. cannot be carried out with the crude sample material. The presence of large amounts of cellular or other contaminating materials, e.g. proteins or carbohydrates, in such complex mixtures often impedes many of the subsequent reactions and techniques. In addition, DNA may contaminate RNA preparations and vice versa. Thus, methods for the efficient, reliable and reproducible isolation of nucleic acids from complex mixtures are needed for many methods that are used today and rely on the identification of DNA or RNA, e.g. diagnosis of microbial infections, forensic science, tissue and blood typing, detection of genetic variations, etc.

Traditional non-magnetic methods {#Sec3}
--------------------------------

### Fluid phase {#Sec4}

A range of methods are known for the isolation of nucleic acids in the fluid phase, but they are generally based on complex series of precipitation and washing steps and are time-consuming and laborious to perform. Thus, classical methods for the isolation of nucleic acids from complex starting materials such as blood or tissues, involve the lysis of the biological material by a detergent or chaotropic substance, possibly in the presence of protein-degrading enzymes, followed by several processing steps applying organic solvents such as phenol and/or chloroform or ethanol, which in general are highly toxic and require special and, hence, expensive disposal. For example, the complete removal of proteins from nucleic acids can be achieved by the addition of sodium perchlorate (Wilcockson [@CR56]). The separation of RNA from DNA requires selective precipitation steps with LiCl or a specific nuclease-free isolation with guanidinium hydrochloride or guanidinium thiocyanate, combined with phenol extraction and ethanol precipitation (Bowtell [@CR8]). Such methods are not only cumbersome and time-consuming, but the relatively large number of steps required increases the risk of degradation, sample loss or cross-contamination of samples especially when several samples are processed simultaneously. In the case of RNA isolation, the risk of DNA contamination is comparatively high.

### Solid phase {#Sec5}

Apart from laborious and time-consuming traditional methods, alternative separation techniques have been developed. Sorption processes based on (a) hydrogen-binding interaction with an underivatised hydrophilic matrix, typically silica, under chaotropic conditions, (b) ionic exchange under aqueous conditions by means of an anion exchanger, (c) affinity and (d) size exclusion mechanisms were used for DNA purification. Solid-phase systems which adsorb DNA---silica-based particles (Vogelstein and Gillespie [@CR52]; Boom et al. [@CR6], [@CR7]; Melzak et al. [@CR31]; Tian et al. [@CR48]; Breadmore et al. [@CR9]), glass fibres, and anion-exchange carriers (Ferreira et al. [@CR19]; Endres et al. [@CR17]; Teeters et al. [@CR47])--are used in chromatographic separation columns \[e.g. DE 41 43 639 C2 (Qiagen GmbH)\] for example.

These carriers are applied for DNA isolation or purification together with highly concentrated chaotropic salt solutions (e.g. sodium iodide, sodium perchlorate, guanidinium thiocyanate). In US 5,075,430 (BioRad), for instance, usage of diatomaceous earth as a carrier material is described. Again, bonding takes place in the presence of a chaotropic salt. Other approaches are based on detergence together with a nucleic-acid-binding material (EP 0 796 327 B1, Dynal) or on the usage of a solid carrier with DNA-binding functional groups combined with polyethylene glycol and salts at high concentrations (WO/1999/058664, Whitehead Institute for Biomedical Research).

Magnetic separation {#Sec6}
-------------------

The increasing use of magnetic solid carriers in biochemical and molecular biology processes has many advantages compared to other non-magnetic separation processes. The term 'magnetic' means that the support obtains a magnetic moment when placed in a magnetic field. Thus, it can be displaced. In other words, particles having a magnetic moment may be removed readily by the application of a magnetic field, e.g. by using a permanent magnet. This is a quick, simple and efficient way to separate the particles after the nucleic binding or elution step (see Fig. [1](#Fig1){ref-type="fig"}) and a far less rigorous method than traditional techniques, such as centrifugation, that generate shear forces which may lead to the degradation of the nucleic acids. It is also possible to isolate components of the cell lysate, which inhibit for example the DNA polymerase of a following PCR reaction like polysaccharides, phenolic compounds or humic substances (Demeke and Adams [@CR14]; Watson and Blackwell [@CR55]). Fig. 1Schematic procedure for nucleic acid purification by magnetic bead technology (illustration by chemagen Biopolymer-Technology AG, Germany)

Usually, it is sufficient to apply a magnet to the side of the vessel containing the sample mixture for aggregating the particles near the wall of the vessel and pouring away the remainder of the sample (see Fig. [1](#Fig1){ref-type="fig"}).

Magnetic carriers with immobilised affinity ligands or prepared from a biopolymer exhibiting affinity to the target nucleic acid are used for the isolation process. Many magnetic carriers are commercially available and can also be prepared in the laboratory. Such materials are magnetic particles produced from different synthetic polymers, biopolymers, porous glass, or magnetic particles based on inorganic magnetic materials such as surface-modified iron oxide. Especially suited are superparamagnetic particles, which do not interact among each other in the absence of a magnetic field. These particles will magnetise under a strong magnetic field, but retain no permanent magnetism once the field is removed. When magnetic aggregation and clumping of the particles are prevented during the reaction, easy suspension of the particles and uniform nucleic acid extraction are ensured.

The diameter of the particles is approximately between 0.5 and 10 μm. Materials with a large surface area are preferred for binding the nucleic acids. Without going into theoretical details, the nucleic-acid-binding process may be assisted by the nucleic acid 'wrapping around' the support. Such supports generally have an irregular surface and may be porous for example. Particulate materials, e.g. beads and in particular polymer beads, are generally preferred due to their larger binding capacity. Conveniently, a particulate solid support used will comprise spherical beads.

Monodisperse particles (particles of mainly uniform size) have the advantage of providing for a very uniform reproducibility of magnetic separation.

Preparation of magnetic particles for nucleic acid separation {#Sec7}
=============================================================

In the laboratory, colloidal magnetite Fe~3~O~4~ (or similar magnetic material such as maghemite γFe~2~O~3~ or ferrites) particles usually are surface-modified by silanisation. Naked iron oxide (Fe~3~O~4~) has the capacity of adsorbing DNA (Davies et al. [@CR13]), but aggregates due to attractive forces reduce the surface area that can be used for adsorption. Silane compounds coupled to magnetite derivatised with carboxyl groups are known to have a DNA extraction ability in solutions containing PEG (Hawkins et al. [@CR22]). Modified bacterial magnetite particles in the presence of amino silane compounds and hyperbranched polyamidoamine dendrimer are used for DNA extraction by Yoza et al. ([@CR57], [@CR58]). Modified magnetic cobalt ferrite particles have been investigated for DNA isolation under high sodium chloride and PEG concentrations by Prodelalova et al. ([@CR38]).

Surface modification of magnetic nanoparticles with alkoxysilanes (Bruce et al. [@CR11]; Tan et al. [@CR46]; Bruce and Sen [@CR10]) or polyethyleneimine (Chiang et al. [@CR12]; Veyret et al. [@CR51]) is also useful. The above-mentioned magnetic colloids are not easy to separate using classical magnets. This is due to a small particle size, at which Brownian motion forces are higher than the exerted magnetic force. To enhance phase separation, various magnetic latexes that may interact with nucleic acids were prepared.

Magnetic micro-beads can be prepared in a number of ways, but usually magnetically susceptible particles (e.g. iron oxide) are coated with synthetic or biological polymers. Elaissari et al. ([@CR16]) describe the interaction of nucleic acids and different polymers. Biopolymers such as agarose, chitosan, κ-carrageenan, and alginate, can be prepared easily in a magnetic form (Levison et al. [@CR30]; Prodelalova et al. [@CR38]). In the simplest case, the biopolymer solution is mixed with magnetic particles and, after bulk gel formation, the magnetic gel formed is broken into fine particles. Alternatively, the biopolymer solution containing dispersed magnetite is dropped into a mixed hardening solution or a water-in-oil suspension technique is used to prepare spherical particles. Basically, the same process can be used to prepare magnetic particles for nucleic separation from synthetic polymers such as hydrophobic polystyrene (Ugelstad et al. [@CR49]) and hydrophilic polyacryl amide (Elaissari et al. [@CR15]) or poly(vinyl alcohol) (Oster et al. [@CR36]). Genomic DNA was also successfully isolated from cell lysate on weak acid derivatives of magnetic P(HEMA-*co*-EDMA) and P(HEMA-*co*-GMA) microparticles in the presence of PEG and sodium chloride (Horak et al. [@CR26]).

The first approach to synthesising micro-sized particles was published by Ugelstad et al. They developed an interesting methodology leading to monosized polystyrene magnetic microspheres, which were studied in various biomedical applications (Ugelstad et al. [@CR50]). These particles have an excellent size distribution and spherical shape, but their surface is very hydrophobic and results in a high amount of unspecific protein binding on the particle surface.

Another possibility consists in combining different polymer matrix materials with silica components (Grüttner et al. [@CR21]; Müller-Schulte et al. [@CR33]) that specifically interact with the nucleic acids.

Depending on the support and the nature of the subsequent processing required, it may or may not be desirable to release the nucleic acid from the support. The direct use of magnetic beads, e.g. in PCR or other amplifications, without eluting the nucleic acid from the surface is not trivial. The enzymatic detection and amplification methods will be inhibited by the magnetic beads, their stabilisers, or their metal oxides (Spanova et al. [@CR44]), which decrease PCR sensitivity or lead to false negative PCR results. For many DNA detections or identification methods, elution is not necessary. Although the DNA may be randomly in contact with the bead surface and bound at a number of points by hydrogen binding or ionic or other forces, there generally will be sufficient lengths of DNA available for hybridisation to oligonucleotides and for amplification. If desired, however, elution of the nucleic acid may be achieved using known methods, e.g. higher ionic strength, heating or pH changes.

Commercially available magnetic particles {#Sec8}
=========================================

Commercially available magnetic particles that are suited for nucleic acid separation can be obtained from a variety of companies. Mostly, the matrixes are based on silica, porous glass, cellulose, agarose, polystyrene and silane (see Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). Moreover, some important patents exist that describe the synthesis of magnetic carriers not only for nucleic separation: Table 1Selection of commercially available magnetic particles used (or suitable) for DNA, RNA and pDNA separationProductDiameter (μm)CompositionSurface area (m^2^ g^−1^)Kind of nucleic acidManufacturer/supplierAGOWA^®^ mag^a^5--10n. k.n. k.DNA, RNAAGOWA, Berlin, GemanyDynabeads^®^DNA^a^1.05, 2.80Polystyrene1--10DNADynal, Oslo, Norway (now Invitrogen)GenoPrep™ DNA magnetic beads^a^n. k.Silica surfacen. k.DNAGenoVision, Oslo, Norway (a Qiagen Company)MagaZorb^®^ ^a^1--10CellulosePorousDNA/RNA pDNACortex Biochem San Leandro, CA, USAMagneSil^a^5--8.5Silanisation of iron oxide27DNA/RNA pDNAPromega, Madison, WI, USAMagPrep^®^Silica particles^b^\~1Silanisation of iron oxide14--25DNAMerck KgaA, GermanyMagSi^b^1, 2, 5n. k.n. k.DNA/RNAMagnaMedics, Aachen, GermanyMGP^c^n. k.Pore-free glass shellNon-porousDNA/RNARoche DiagnosticM-PVA^a^0.5--1, 1--3, 5--8Polyvinyl alcoholNon-porousDNA/RNA pDNAchemagen Biopolymer Technology, Baesweiler, GermanySicastar^®^-M^b^1.5, 6Sterene-maleic acid copolymerNon-porousDNAMicromod Partikeltechnologie, Rostock, GermanySiMAG^a^0.5, 0.75, 1Silanisation of iron oxide100DNA/RNA pDNAChemicell, Berlin, GermanySPHERO magnetic particles^b^1--2PolystyreneNon-porousDNASpherotech, Libertyville, IL, USA^a^Kits and protocols available^b^No kits and protocols available^c^Only kit available without any information*n. k.* not known Table 2Selection of commercially available magnetic particles used (or suitable) for mRNA separationProductDiameter (μm)Polymer composition / surface modificationSurface area (m^2^ g^−1^)Manufacturer/supplierBcMag^®^ mRNA1 or 5Silanisation of iron oxiden. k.Bioclone, San Diego, CA, USABioMag^®^ oligo (dT)20∼1Silanisation of iron oxide100Bangs Lab., Fisher, IN, USA or Polysciences, USADynabeads^®^ oligo (dT)251.05, 2.8 μmPolystyrene1--10Dynal, Oslo, Norway (now Invitrogen)μMACS oligo-dT0.05DextranNon-porousMiltenyi Biotech, Bergisch Gladbach, GermanyMagaCell™ oligo-dT~30~1--10CellulosePorousCortex Biochem, San Leandro, CA, USAMagneSphere^®^∼1Streptavidin-coated magnetite100--150Promega, Madison, WI, USAMPG^®^ streptavidin oligo (dT)25∼5Porous borosilicate glass60PureBiotech, Middlesex, NJ, USAM-PVA-oligo (dT)30Various (0.5--1; 1--3; 5--8)Polyvinyl alcoholNon-porouschemagen AG, Baesweiler, GermanymRNA-cellulose1--10Cellulosen. k.Scipac Ltd., Sittingbourne, UKNucleo-Adembeads0.1--0.5Polymer100Ademtech, Pessac, FranceScigen M100 oligo (dT)30∼3.5Cellulose10Vector Lab., Burlingame, USASera-Mag oligo (dT)301PolystyreneNon-porousSeradyn, Indianapolis, IN, USA*n. k.* not known

One of the first patents for particle synthesis is the 'Ugelstad polymerization process', which is described, for example, in EP 0 003 905 B2, US 5,459,378, and US 4,530,956 (SINTEF). It leads to monodisperse magnetic particles by several swelling and polymerisation steps. WO/1992/016581 (Cornell Research Foundation) also describes the preparation of monodisperse particles, particularly macroporous polymer beads. The process proposed uses a three-phase emulsion containing soluble polymer particles, a monomer phase and water. Nucleic acid separation using magnetic beads is described in (Alderton et al. [@CR2]) and in WO/1991/012079 as well as in US 5,523,231 (Amersham). These magnetic beads are able to absorb the nucleic acid after a salt-ethanol precipitation. The approaches are not nucleic-acid-specific, i.e. the magnetic beads adsorb other bio-substances in parallel. Of course, this is a drawback of these approaches.

In the declaration WO/1996/041811 (Boehringer; Roche) mainly non-porous glass particles comprising mica and magnetite particles are described (Bartl et al. [@CR3]). During their production, magnetic particles and a surrounding glass coating are superimposed on a mica core. The disadvantage of these products is their affinity to sedimentation. Furthermore, the production process is time-consuming and based on a complex spray process. Another approach to the production of particles from spherical magnetite kernels with a surface coating of silicon dioxide is covered by the European patent application EP 1 468 430 A1.

Monodisperse magnetic beads are described in WO/1998/012717 (Merck). They consist of a SiO~2~ core, which is given magnetic properties by a ferric-oxide coating. After a subsequent silanisation of the ferric-oxide coating, the particles can bind nucleic acids.

Many patents concerning nucleic acid separation are from the Dynal company. They developed monodisperse polymer magnetic particles with different sizes (coefficient of variation less than 5%) (see EP 0 796 327 B1), which are sold with a polystyrene matrix under the name of Dynabeads^®^. The small-size distribution ensures reproducible separation properties. Protocols for nucleic acid separation with these particles are described by EP 0 512 439 B1 and with oligonucleotide-linked particles for specific nucleic acid separation in US 5,512,439.

Magnetic beads based on mica or polystyrene and coated by a magnetic oxide reach a high specific density, which leads to a fast sedimentation. Thus, additional mechanical mixing is necessary. The main drawback of the coated particles consists in the fact that the metal oxides may be in direct contact with the analytical solutions despite silanisation. All state-of-the-art approaches to the production of magnetic beads are laborious; the production process time amounts to several hours. To overcome this problem, the US patents 6,204,033 and 6,514,688 (chemagen Biopolymer Technologie AG) describe spherical, magnetic polymer particles based on polyvinyl alcohol particles, which can be produced in short terms using inverse suspension polymerisation. The polymer particles contain reactive hydroxyl groups to which other molecules can be coupled. Due to their hydrophilic surface, the particles exhibit small unspecific bindings only. Together with an at least partly silanised surface (DE 100 13 955 A1 and EP 1 274 745 A1) or a germanium-containing compound (DE 101 03 652 A1), they can be used for specific nucleic acid separation.

The inverse suspension process for the separation of nano- and micro-sized silica particles is suggested in WO/2002/009125 (Fraunhofer-Gesellschaft). The main idea is the dispersion of aqueous silica-sole containing magnetic colloids, which are hardened to spherical hydrophilic gel particles by adding a suited base. These particles can be used for nucleic acid separation with high binding capacities (WO/2005/50 52 581 A3, MagnaMedics GmbH).

Total DNA/RNA {#Sec9}
-------------

Both total DNA and RNA are separated by the same magnetic beads. For the purpose of removing RNA from DNA, the RNA is destroyed before the DNA separation step. Adding of an RNAse or an alkali such as NaOH is an appropriate process. Vice versa, RNA can be separated if the DNA is degraded with DNAse.

Plasmid DNA {#Sec10}
-----------

The primary method considered for plasmid purification is the separation of plasmid DNA (pDNA) from the chromosomal DNA and cellular RNA of the host bacteria. Stadler et al. ([@CR45]) show that even in the case of a high copy plasmid, pDNA represents not more than 3% of the cleared lysate and that most of the critical contaminants are negatively charged (RNA, cDNA, endotoxin) and similar in size (cDNA, endotoxins) and hydrophobicity (endotoxins). A number of methods have been developed to generate a cleared lysate, but they are not able to remove proteins and lipids. Alkaline lysis of harvested bacterial cells with a subsequent neutralisation, as originally described by Birnboim and Doly ([@CR5]), is the process of choice. Cleared lysate protocols may vary slightly from each other as regards salt concentrations, volume, pH, temperature, and process step durations (Hirt [@CR24]; Holmes and Quigley [@CR25]; Birnboim [@CR4]). These techniques make use of the differences in denaturation and renaturation characteristics of covalently closed circular plasmid DNA and chromosomal DNA fragments.

For example, superparamagnetic nano particles modified by multivalent cationic polyethyleneimine are used to isolate pDNA from cleared bacterial lysate (Chiang et al. [@CR12]).

Table [1](#Tab1){ref-type="table"} shows some commercially available magnetic particles used for DNA, RNA and pDNA isolation. Many magnetic particles are available with optimised buffers and protocols for small lab scale and automated systems. There are also some companies offering particles for nucleic acid purification without any further information.

Affinity capture of RNA and DNA {#Sec11}
-------------------------------

The magnetic carrier is provided with binding solutions to assist in the selective capture of nucleic acids. For example, complementary DNA or RNA sequences (Satokari et al. [@CR43]) or DNA-binding proteins may be used as well as viral proteins binding to viral nucleic acids. In this review, a short overview of eukaryotic mRNA and viral DNA/RNA will be given.

There are several companies (see Table [2](#Tab2){ref-type="table"}) offering oligodeoxythymidine immobilised with magnetic particles, which can be used effectively for the rapid isolation of highly purified mRNA from eukaryotic cell cultures or total RNA preparations (Jacobsen et al. [@CR29]). These procedures are based on the hybridisation of the oligonucleotide dT sequence with the stable polyadenylated 3 termini of the eukaryotic mRNA. The length of the complementary sequence differs between 20 and 30 oligonucleotides. This sequence is directly bound covalently to the particle surface or indirectly by biotinylated oligonucleotides and the interaction of streptavidin-coated particles. CPG and Dynal (now Invitrogen) offer MPG^®^ and Dynabeads^®^ with already immobilised biotinylated oligonucleotide, but also other companies offer streptavidin-modified particles, which can be used for mRNA isolation, as described, e.g. by the mRNA isolation kit with MagneSphere^®^ from Promega. Nearly all magnetic particles (except for MagaCell™ oligo-dT~30~ and Sera-Mag oligo-(dT)~30~) are available together with an optimised buffer system and helpful protocols.

Automated extraction of viral RNA and DNA from the plasma mini-pool is performed by the chemagic Viral DNA/RNA Kit and chemagic Magnetic Separation Module I (Hourfar et al. [@CR27],[@CR28]; Pichl et al. [@CR37]).

A rapid diagnosis of enterovirus infection by magnetic bead extraction has been established by Muir et al. ([@CR32]). Enterovirus RNA can be separated from large-volume water samples using the NucliSens miniMAG System (Rutjes et al. [@CR40]). Hei and Cai ([@CR23]) developed a system for purifying SARS coronavirus RNA by a hybridisation of a specific oligonucleotide sequence, which is immobilised on the magnetic bead surface.

Magnetic separators {#Sec12}
===================

A variety of magnetic separators are available on the market, ranging from very simple concentrators for one tube to complicated fully automated devices. The isolation of nucleic acids is mostly performed in the batch mode using commercially available lab-scale magnetic separators (particle concentrators). Separators are usually made of strong rare-earth permanent magnets designed to hold various amounts of micro-tubes or tubes.

Particles with a diameter larger than 1 μm can be separated easily using simple magnetic separators, while separation of smaller particles (magnetic colloids with a particle size ranging from ten to hundreds of nanometres) may require the use of high-gradient magnetic separators.

Many different companies that mostly offer magnetic particles also have batch separators in their portfolio. A selection of commercially available batch-type magnetic separators is given in Table [3](#Tab3){ref-type="table"}. Table 3Selection of commercially available batch-type magnetic separatorsCompanySeparatorDescriptionAdemtechAdem-Mag9696-well plateAutoMag12 × 1.5 ml reaction tubes (mixing and separation)AGOWA GmbHAGOWA^®^Sep 960096-well plate (temperature can be adjusted, pc-controllable)AGOWA^®^Sep 720048-well plateAGOWA^®^maxisepPLUS 240024-well plate (5 ml volume)Bangs Laboratories, Inc.BioMag^®^multi-6microcentrifuge Tube separator96-well plateBioMag^®^96-well Plate separatorBioclone, Inc.Bc^®^Mag magnetic separator-22 × 1.5 ml tubesBc^®^Mag magnetic separator-66 × 1.5 ml tubesBc^®^Mag magnetic separator-2424 × 1.5 ml or 2 ml tubesBc^®^Mag magnetic separator-501 × 50 ml + 1 × 15 ml tubeschemagen Biopolymer-Technologie AGchemagen stand 2 × 1212 × 1.5 ml + 12 × 2 ml tubeschemagen stand 9696-well platechemagen stand 50 k Type A10--50 ml total volumechemagen stand 50 k Type Bmax. 15 ml volumechemagen stand MultiTube16 × 50 ml (overturn)Chemicell GmbHMagnetoPure2 × 1.5 ml + 2 × 2 ml tubesCortex Biochem96-well plate magnetic separatorbottom pull and side pullCPG, Inc.3-in-1 MPS^®^8 × 1.5 ml or 1 × 15 ml + 1 × 1.5 ml or 1 × 50 ml + 1 × 1.5 ml96-Well MPS^®^96-well plateKisker GmbHMagna separation rack5 × 1.5/2 ml for separation plus 5 × 1.5/2 ml for storageVariMag separation rackThree different combinationsUltraMag separation rack96-well plateMiltenyi Biotech GmbHMACS™ separatorsDifferent modelsPromegaMagnaBot^®^96 magnetic separation device96-well plate

The racks are designed to hold various amounts of micro-tubes or tubes. Test tube magnetic separators allow to separate magnetic particles from volumes between approximately 5 μl and 50 ml. There are many combinations with other features like a mixing function (Ademtech) or a possibility to turn the separator over for the removal of the supernatant (chemagen Biopolymer-Technologie AG). Other devices are applied for the separation of magnetic particles from the wells of standard micro-titration plates. In some of them the temperature can be pc-controlled (AGOWA), other devices may be inserted into automated separation devices.

Laboratory automation is increasingly important in molecular biology and biotechnology. Constantly increasing numbers of analyses of different sources and sample volumes have resulted in an enormous importance of flexible robots or automated systems. Automation is also required for handling a large number of samples without human errors.

Many instruments have been developed to automate PCR amplification, the sequencing reaction and the detection of nucleic acids, but automating DNA extraction by traditional methods with centrifugation and vacuum steps still is difficult. A complete separation of the solid carrier matrix by centrifugation is not possible. Supports filled with carrier materials cannot be used, as the ineluctable dead volumes of the support lead to sample material loss in case of small amounts of sample materials. Another drawback is the danger of mutual contamination of different biological samples, especially if directly neighbouring supports are emptied by the vacuum. However, the last decade shows that DNA purification using magnetic bead technology is suitable for automation systems, and several automated instruments for handling magnetic beads have been developed (Alderton et al. [@CR2]; Wahlberg et al. [@CR54]; Rolfs and Weber [@CR39]; Fangan et al. [@CR18]; Obata et al. [@CR34]; Akutsu et al. [@CR1]; Vuosku et al. [@CR53]).

More and more vendors offer commercially automated devices for the handling of magnetic particles, e.g. for the purification of nucleic acid (see Table [4](#Tab4){ref-type="table"}). Most systems are offered together with system-specific optimised particles, buffer systems and protocols. Table 4Selection of commercially available automated magnetic separatorsCompanyDeviceSamples in parallelSamples per runSample volume^a^High throughput chemagen Biopolymer-Technologie AGchemagic MSM I (96 rod head)969610--400 μl Qiagen GmbHBioSprint^®^969696100 μl or 200 μl Thermo LabsystemsKingFisher^®^96See BioSprint^®^96 (Qiagen GmbH)Low and medium throughput; large volumes chemagen Biopolymer-Technologie AGChemagic MSM I (12 rod head)12121--10 ml PromegaMaxwell™ 16161610--400 μl PSS Bio InstrumentsMagtration^®^System 8Lx887 ml Qiagen GmbHBioRobot^®^M48648max. 200 μlBioRobot^®^EZ166max. 200 μlBioRobot^®^15151550--1,000 μl Roche Diagnostics GmbHMagNa Pure Compact88100--1,000 μlMagNa Pure LC832100--1,000 μlCobas^®^AmpliPrep172250--1,500 μl Themo LabsystemsKingFisher^®^MLSee BioRobot^®^15 (Qiagen GmbH) GenoVisionGenoM™-6See BioRobot^®^EZ1 (Qiagen GmbH)^a^Whole blood; other applications available

The devices are able to process between six and 96 samples in parallel and commonly customised for small buffer volumes. For larger volumes, the chemagic Magnetic Separation Module I (\<10 ml) (see Fig. [2](#Fig2){ref-type="fig"}) or the Magtration^®^ System 8 l × (7 ml) can be used. Fig. 2chemagic Magnetic Separation Module I consisting of (*A*) separation head with magnetizable rods \[here 12-well format for large (50 ml) volumes; 96-well format for MTPs also available\], (*B*) electro magnet, (*C*) chemagic dispenser for parallel filling of all required buffer solutions (accessory) and (*D*) tracking unit. The principle functionality regarding separation and resuspension of magnetic beads is shown in the scheme

Conclusion {#Sec13}
==========

The present review has shown that the separation of nucleic acid is a highly dynamic field of research and development. An increasing number of commercial vendors offer magnetic particles, also in the form of a kit that is optimally suited for the application desired. The increasing number of publications shows that magnetic particles of higher potential are currently under research. Materials with more specific-binding properties and a better separability are promising approaches. A higher degree of automation leads to systems analysing a larger number of samples and higher sample volumes at the same time.

Up to now, however, no real scale-up for the purification of large volumes (in the scale of litres) has been realised.
